drugset / Trial / NCT02016742
A Phase 1 Study of the Pharmacokinetics of RDC5 in Healthy Volunteers
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to characterise the pharmacokinetics, safety and tolerability of RDC5 given as a single dose to healthy volunteers at a number of different dose levels
Timeline
- Start
- 2013-12
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RDC5 | Unknown | — | — |
Indications
No indication recorded.